Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.54
-1.46 (-5.41%)
Nov 6, 2026, 4:00 PM EST - Market closed

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,2303,5571,6303059011,043
Market Cap Growth
6.49%118.17%434.82%-66.18%-13.58%-14.88%
Enterprise Value
3,0943,4801,508283626681
Last Close Price
27.0029.0413.933.2314.8020.74

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
32.8276.62----
PS Ratio
6.379.468.305.11244.56-
PB Ratio
13.9518.7710.353.444.303.50
P/TBV Ratio
14.0320.3611.013.714.453.50

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.109.257.674.75169.88-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.510.600.702.320.970.26
Debt / FCF Ratio
2.07-----
Net Debt / Equity Ratio
-0.56-0.56-0.75-0.74-0.99-1.04
Net Debt / EBITDA Ratio
-3.6214.080.940.270.691.50
Net Debt / FCF Ratio
-2.2716.871.050.270.801.76
Asset Turnover
1.140.960.570.150.01-
Inventory Turnover
1.321.981.380.48--
Quick Ratio
2.502.833.726.3811.0611.61
Current Ratio
2.923.174.147.0811.5712.09
Return on Equity (ROE)
14.88%-9.30%-113.76%-175.79%-122.80%-72.62%
Return on Assets (ROA)
4.91%-1.96%-23.25%-38.12%-43.97%-36.55%
Return on Capital Employed (ROCE)
10.00%-4.00%-47.90%-81.80%-73.30%-55.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.85%-0.45%-8.59%-85.99%-34.55%-19.78%
FCF Yield
1.84%-0.18%-6.89%-81.18%-28.63%-16.84%
Buyback Yield / Dilution
-6.17%-5.19%-74.53%-25.94%-11.39%-38.52%
SEC Filings: 10-K · 10-Q